ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor, Reduces Tumor Microvascularity and Improves Vascular Wall Integrity in Preclinical Tumor Models
Jiang, F., Albert, D. H., Luo, Y., Tapang, P., Zhang, K., Davidsen, S. K., Fox, G. B., Lesniewski, R., McKeegan, E. M.Volume:
338
Language:
english
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.110.178061
Date:
July, 2011
File:
PDF, 1.68 MB
english, 2011